Form 10-Q TANDEM DIABETES CARE For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Tandem Diabetes Care (TNDM) PT Lowered to $51 at Barclays
August 7, 2025 8:27 AM EDTBarclays analyst Matt Miksic lowered the price target on Tandem Diabetes Care (NASDAQ: TNDM) to $51.00 (from $53.00) while maintaining a Overweight rating.
The analyst comments "Q2 sales were a touch above consensus, with upside OUS offset by a shortfall in the U.S. Mgmt... More
